178 related articles for article (PubMed ID: 28245778)
1. Curcumin: Not So Spicy After All.
Jha A; Mohapatra PP; AlHarbi SA; Jahan N
Mini Rev Med Chem; 2017; 17(15):1425-1434. PubMed ID: 28245778
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathways Modulated by Curcumin Analogue, Diarylpentanoids in Cancer.
Paulraj F; Abas F; H Lajis N; Othman I; Naidu R
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31295798
[TBL] [Abstract][Full Text] [Related]
3. Insights into the importance for designing curcumin-inspired anticancer agents by a prooxidant strategy: The case of diarylpentanoids.
Dai F; Liu GY; Li Y; Yan WJ; Wang Q; Yang J; Lu DL; Ding DJ; Lin D; Zhou B
Free Radic Biol Med; 2015 Aug; 85():127-37. PubMed ID: 25912482
[TBL] [Abstract][Full Text] [Related]
4. Diarylpentanoids with antitumor activity: A critical review of structure-activity relationship studies.
Moreira J; Saraiva L; Pinto MM; Cidade H
Eur J Med Chem; 2020 Apr; 192():112177. PubMed ID: 32172081
[TBL] [Abstract][Full Text] [Related]
5. Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis.
Hahm ER; Gho YS; Park S; Park C; Kim KW; Yang CH
Biochem Biophys Res Commun; 2004 Aug; 321(2):337-44. PubMed ID: 15358181
[TBL] [Abstract][Full Text] [Related]
6. Design and Synthesis of Curcumin-Like Diarylpentanoid Analogues as Potential Anticancer Agents.
Qudjani E; Iman M; Davood A; Ramandi MF; Shafiee A
Recent Pat Anticancer Drug Discov; 2016; 11(3):342-51. PubMed ID: 27094172
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological assessment of novel N-(hydroxy/methoxy)alkyl β-enaminone curcuminoids.
Theppawong A; De Vreese R; Vannecke L; Grootaert C; Van Camp J; D'hooghe M
Bioorg Med Chem Lett; 2016 Dec; 26(23):5650-5656. PubMed ID: 27843113
[TBL] [Abstract][Full Text] [Related]
8. Curcumin and its analogues: potential anticancer agents.
Agrawal DK; Mishra PK
Med Res Rev; 2010 Sep; 30(5):818-60. PubMed ID: 20027668
[TBL] [Abstract][Full Text] [Related]
9. A Review of Curcumin and Its Derivatives as Anticancer Agents.
Tomeh MA; Hadianamrei R; Zhao X
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818786
[TBL] [Abstract][Full Text] [Related]
10. Hexamethoxylated Monocarbonyl Analogues of Curcumin Cause G2/M Cell Cycle Arrest in NCI-H460 Cells via Michael Acceptor-Dependent Redox Intervention.
Li Y; Zhang LP; Dai F; Yan WJ; Wang HB; Tu ZS; Zhou B
J Agric Food Chem; 2015 Sep; 63(35):7731-42. PubMed ID: 26255837
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Cytotoxic Evaluation of Monocarbonyl Analogs of Curcumin as Potential Anti-Tumor Agents.
Pan Z; Chen C; Zhou Y; Xu F; Xu Y
Drug Dev Res; 2016 Feb; 77(1):43-9. PubMed ID: 26846154
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in the Development of "Curcumin Inspired" Compounds as New Therapeutic Agents.
Borosky GL; Laali KK
Mini Rev Med Chem; 2020; 20(15):1543-1558. PubMed ID: 32384026
[TBL] [Abstract][Full Text] [Related]
13. All trans 1-(3-arylacryloyl)-3,5-bis(pyridin-4-ylmethylene)piperidin-4-ones as curcumin-inspired antineoplastics.
Paul NK; Jha M; Bhullar KS; Rupasinghe HP; Balzarini J; Jha A
Eur J Med Chem; 2014 Nov; 87():461-70. PubMed ID: 25282269
[TBL] [Abstract][Full Text] [Related]
14. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
[TBL] [Abstract][Full Text] [Related]
15. Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis.
Baldwin PR; Reeves AZ; Powell KR; Napier RJ; Swimm AI; Sun A; Giesler K; Bommarius B; Shinnick TM; Snyder JP; Liotta DC; Kalman D
Eur J Med Chem; 2015 Mar; 92():693-9. PubMed ID: 25618016
[TBL] [Abstract][Full Text] [Related]
16. Developments in the anticancer activity of structurally modified curcumin: An up-to-date review.
Rodrigues FC; Anil Kumar NV; Thakur G
Eur J Med Chem; 2019 Sep; 177():76-104. PubMed ID: 31129455
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitizing effects of synthetic curcumin analogs on human multi-drug resistance leukemic cells.
Mapoung S; Pitchakarn P; Yodkeeree S; Ovatlarnporn C; Sakorn N; Limtrakul P
Chem Biol Interact; 2016 Jan; 244():140-8. PubMed ID: 26689174
[TBL] [Abstract][Full Text] [Related]
18. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity.
Banerjee S; Chakravarty AR
Acc Chem Res; 2015 Jul; 48(7):2075-83. PubMed ID: 26158541
[TBL] [Abstract][Full Text] [Related]
19. Curcumin analogues and derivatives with anti-proliferative and anti-inflammatory activity: Structural characteristics and molecular targets.
Chainoglou E; Hadjipavlou-Litina D
Expert Opin Drug Discov; 2019 Aug; 14(8):821-842. PubMed ID: 31094233
[No Abstract] [Full Text] [Related]
20. Monocarbonyl Analogs of Curcumin with Potential to Treat Colorectal Cancer.
Clariano M; Marques V; Vaz J; Awam S; Afonso MB; Jesus Perry M; Rodrigues CMP
Chem Biodivers; 2023 Mar; 20(3):e202300222. PubMed ID: 36807727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
